Vis enkel innførsel

dc.contributor.authorMäkelä, Keijo T.en_US
dc.contributor.authorMatilainen, Markusen_US
dc.contributor.authorPulkkinen, Pekkaen_US
dc.contributor.authorFenstad, Anne Marieen_US
dc.contributor.authorHavelin, Leif Ivaren_US
dc.contributor.authorEngesæter, Lars B.en_US
dc.contributor.authorFurnes, Oveen_US
dc.contributor.authorOvergaard, Sørenen_US
dc.contributor.authorPedersen, Alma Becicen_US
dc.contributor.authorKärrholm, Johanen_US
dc.contributor.authorMalchau, Henriken_US
dc.contributor.authorGarellick, Göranen_US
dc.contributor.authorRanstam, Jonasen_US
dc.contributor.authorEskelinen, Anttien_US
dc.date.accessioned2015-10-16T07:42:22Z
dc.date.available2015-10-16T07:42:22Z
dc.date.issued2014
dc.PublishedActa Orthopaedica 2014, 85(2):107-116eng
dc.identifier.issn1745-3682
dc.identifier.urihttps://hdl.handle.net/1956/10575
dc.description.abstractBackground and purpose: An earlier Nordic Arthroplasty Register Association (NARA) report on 280,201 total hip replacements (THRs) based on data from 1995–2006, from Sweden, Norway, and Denmark, was published in 2009. The present study assessed THR survival according to country, based on the NARA database with the Finnish data included. Material and methods: 438,733 THRs performed during the period 1995–2011 in Sweden, Denmark, Norway, and Finland were included. Kaplan-Meier survival analysis was used to calculate survival probabilities with 95% confidence interval (CI). Cox multiple regression, with adjustment for age, sex, and diagnosis, was used to analyze implant survival with revision for any reason as endpoint. Results: The 15-year survival, with any revision as an endpoint, for all THRs was 86% (CI: 85.7–86.9) in Denmark, 88% (CI: 87.6–88.3) in Sweden, 87% (CI: 86.4–87.4) in Norway, and 84% (CI: 82.9–84.1) in Finland. Revision risk for all THRs was less in Sweden than in the 3 other countries during the first 5 years. However, revision risk for uncemented THR was less in Denmark than in Sweden during the sixth (HR = 0.53, CI: 0.34–0.82), seventh (HR = 0.60, CI: 0.37–0.97), and ninth (HR = 0.59, CI: 0.36–0.98) year of follow-up. Interpretation: The differences in THR survival rates were considerable, with inferior results in Finland. Brand-level comparison of THRs in Nordic countries will be required.en_US
dc.language.isoengeng
dc.publisherTaylor & Franciseng
dc.rightsAttribution CC BY-NCeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/eng
dc.titleCountrywise results of total hip replacement. An analysis of 438,733 hips based on the Nordic Arthroplasty Register Association databaseen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2015-07-28T09:45:21Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright Nordic Orthopaedic Federation
dc.identifier.doihttps://doi.org/10.3109/17453674.2014.893498
dc.identifier.cristin1152323
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Ortopedisk kirurgi: 784
dc.subject.nsiVDP::Midical sciences: 700::Clinical medical sciences: 750::Orthopaedic surgery: 784


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY-NC
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY-NC